Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 4,321 shares at $15.85 ($69K) on 2018-12-03, disclosed to the SEC on 2018-12-06.
Scheduled sale ($69k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.85 | 1,306 | $21K | 29.8% |
| 2 | $16.15 | 3,015 | $49K | 70.2% |
| Total | $16.06 avg | 4,321 | $69K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |